β-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53

Cédric Boularan, Mark G. H. Scott, Karima Bourougaa, Myriam Bellal, Emmanuel Estève, Alain Thuret, Alexandre Benmerah, Marc Tramier, Maïté Coppey‐Moisan, Catherine Labbé‐Jullié,

Proceedings of the National Academy of Sciences · 2007 · 66 citations · 30 references

DOIFull text

Open access

Concepts

Abstract

beta-arrestins (beta-arrs), two ubiquitous proteins involved in serpentine heptahelical receptor regulation and signaling, form constitutive homo- and heterooligomers stabilized by inositol 1,2,3,4,5,6-hexakisphosphate (IP6). Monomeric beta-arrs are believed to interact with receptors after agonist activation, and therefore, beta-arr oligomers have been proposed to represent a resting biologically inactive state. In contrast to this, we report here that the interaction with and subsequent titration out of the nucleus of the protooncogene Mdm2 specifically require beta-arr2 oligomers together with the previously characterized nucleocytoplasmic shuttling of beta-arr2. Mutation of the IP6-binding sites impair oligomerization, reduce interaction with Mdm2, and inhibit p53-dependent antiproliferative effects of beta-arr2, whereas the competence for receptor regulation and signaling is maintained. These observations suggest that the intracellular concentration of beta-arr2 oligomers might control cell survival and proliferation.

References

30